Rockwell Medical Share Price (NASDAQ: RMTI)

$1.71

▲

-0.09

(-5%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Rockwell Medical Stock chart to analyse performance

Rockwell Medical stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$1.42
Today's High:$2.06
$1.71
16.96%
Downside
Day's Volatility :31.07%
Upside
16.99%
52 Weeks Low:$0.78
52 Weeks High:$5.15
$1.71
54.38%
Downside
52 Weeks Volatility :84.85%
Upside
66.8%

Rockwell Medical Stock Returns

Period	Rockwell Medical Inc	Index (Russel 2000)
3 Months	71.76%	0.0%
6 Months	7.55%	0.0%
1 Year	-47.22%	0.0%
3 Years	-8.06%	-4.7%

Rockwell Medical Inc Key Stats

Check Rockwell Medical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.8
Open	$1.99
Today's High	$2.06
Today's Low	$1.42
Market Capitalization	$62.0M
Today's Volume	$7.6M
52 Week High	$5.15
52 Week Low	$0.7801
Revenue TTM	$88.0M
EBITDA	$896.0K
Earnings Per Share (EPS)	$-0.07
Profit Margin	-2.39%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-7.79%

Stock Returns calculator for Rockwell Medical Stock including INR - Dollar returns

The Rockwell Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Rockwell Medical investment value today

Current value as on today

₹58,062

Returns

₹41,938

(-41.94%)

Returns from Rockwell Medical Stock

₹47,222 (-47.22%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Rockwell Medical Stock

307%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Rockwell Medical Stock from India on INDmoney has increased by 307% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Rockwell Medical Inc

Name
Holdings %
Name
Holdings %
Armistice Capital, LLC
6.24%
Vanguard Group Inc
3.50%
Renaissance Technologies Corp
1.32%
Geode Capital Management, LLC
0.94%
GlobeFlex Capital, L.P.
0.91%
BlackRock Inc
0.64%

Analyst Recommendation on Rockwell Medical Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Rockwell Medical(by analysts ranked 0 to 5 stars)

Rockwell Medical Share Price Target

What analysts predicted

Upside of 133.92%

Target:

$4.00

Current:

$1.71

Rockwell Medical share price target is $4.00, a slight Upside of 133.92% compared to current price of $1.71 as per analysts' prediction.

Rockwell Medical Stock Insights

Price Movement
In the last 7 days, RMTI stock has moved up by 50.0%
Decreasing Revenue
Revenue is down for the last 4 quarters, 28.31M → 16.07M (in $), with an average decrease of 17.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.51M → -1.49M (in $), with an average increase of 1.5% per quarter
RMTI vs NBIX (1 yr)
In the last 1 year, Neurocrine Biosciences Inc. has given 9.9% return, outperforming this stock by 50.1%
RMTI vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 35.1% return, outperforming this stock by 28.2%
Price to Sales
ForRMTI every $1 of sales, investors are willing to pay $0.6, whereas for Neurocrine Biosciences Inc., the investors are paying $5.6 for every $1 of sales.

Rockwell Medical Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$61.3M	↓ 3.29%
Net Income	$-34.1M	↑ 6.23%
Net Profit Margin	-55.67%	↓ 4.99%

	FY20	Y/Y Change
Revenue	$62.2M	↑ 1.46%
Net Income	$-30.9M	↓ 9.49%
Net Profit Margin	-49.66%	↑ 6.01%

	FY21	Y/Y Change
Revenue	$61.9M	↓ 0.43%
Net Income	$-32.7M	↑ 5.78%
Net Profit Margin	-52.76%	↓ 3.1%

	FY22	Y/Y Change
Revenue	$72.8M	↑ 17.57%
Net Income	$-18.7M	↓ 42.83%
Net Profit Margin	-25.65%	↑ 27.11%

	FY23	Y/Y Change
Revenue	$83.6M	↑ 14.84%
Net Income	$-8.4M	↓ 54.82%
Net Profit Margin	-10.09%	↑ 15.56%

	FY24	Y/Y Change
Revenue	$101.5M	↑ 21.38%
Net Income	$-480.0K	↓ 94.31%
Net Profit Margin	-0.47%	↑ 9.62%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$22.7M	↑ 2.64%
Net Income	$-1.7M	↑ 14.48%
Net Profit Margin	-7.63%	↓ 0.79%

	Q2 FY24	Q/Q Change
Revenue	$25.8M	↑ 13.92%
Net Income	$343.0K	↓ 119.82%
Net Profit Margin	1.33%	↑ 8.96%

	Q3 FY24	Q/Q Change
Revenue	$28.3M	↑ 9.62%
Net Income	$1.7M	↑ 385.13%
Net Profit Margin	5.88%	↑ 4.55%

	Q4 FY24	Q/Q Change
Revenue	$24.7M	↓ 12.89%
Net Income	$-756.0K	↓ 145.43%
Net Profit Margin	-3.07%	↓ 8.95%

	Q1 FY25	Q/Q Change
Revenue	$18.9M	↓ 23.32%
Net Income	$-1.5M	↑ 100.4%
Net Profit Margin	-8.01%	↓ 4.94%

	Q2 FY25	Q/Q Change
Revenue	$16.1M	↓ 15.03%
Net Income	$-1.5M	↓ 1.52%
Net Profit Margin	-9.28%	↓ 1.27%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$2.8M	↓ 279.17%

	FY20	Y/Y Change
Profit	$2.7M	↓ 4.01%

	FY21	Y/Y Change
Profit	$-2.4M	↓ 188.81%

	FY22	Y/Y Change
Profit	$4.1M	↓ 268.47%

	FY23	Y/Y Change
Profit	$8.7M	↑ 113.49%

	FY24	Y/Y Change
Profit	$17.5M	↑ 100.87%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$3.1M	↑ 6.76%

	Q2 FY24	Q/Q Change
Profit	$4.6M	↑ 48.5%

	Q3 FY24	Q/Q Change
Profit	$6.2M	↑ 37.12%

	Q4 FY24	Q/Q Change
Profit	$3.6M	↓ 41.8%

	Q1 FY25	Q/Q Change
Profit	$3.0M	↓ 16.22%

	Q2 FY25	Q/Q Change
Profit	$2.5M	↓ 17.72%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-27.3M	↑ 33.47%
Investing Cash Flow	$-4.7M	↓ 137.33%
Financing Cash Flow	$21.1M	↓ 4.17%

	FY20	Y/Y Change
Operating Cash Flow	$-29.6M	↑ 8.76%
Investing Cash Flow	$3.2M	↓ 167.62%
Financing Cash Flow	$63.3M	↑ 200.29%

	FY21	Y/Y Change
Operating Cash Flow	$-33.5M	↑ 13.13%
Investing Cash Flow	$311.0K	↓ 90.32%
Financing Cash Flow	$-2.2M	↓ 103.44%

	FY22	Y/Y Change
Operating Cash Flow	$-17.4M	↓ 48.07%
Investing Cash Flow	$-2.4M	↓ 870.42%
Financing Cash Flow	$16.2M	↓ 841.17%

	FY23	Y/Y Change
Operating Cash Flow	$-9.4M	↓ 45.95%
Investing Cash Flow	$-3.0M	↑ 27.09%
Financing Cash Flow	$11.3M	↓ 29.77%

	FY24	Y/Y Change
Operating Cash Flow	$4.2M	↓ 144.65%
Investing Cash Flow	$-4.9M	↑ 59.8%
Financing Cash Flow	$7.3M	↓ 35.21%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-2.4M	↑ 5434.88%
Investing Cash Flow	$-139.0K	↓ 106.92%
Financing Cash Flow	$178.0K	↓ 123.99%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.4M	↓ 160.59%
Investing Cash Flow	$1.7M	↓ 1335.25%
Financing Cash Flow	$2.1M	↑ 1060.11%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$4.3M	↑ 196.46%
Investing Cash Flow	$-6.1M	↓ 455.97%
Financing Cash Flow	$2.3M	↑ 12.01%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$865.0K	↓ 79.77%
Investing Cash Flow	$-332.0K	↓ 94.57%
Financing Cash Flow	$2.8M	↑ 20.71%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-3.5M	↓ 503.12%
Investing Cash Flow	$-1000.0	↓ 99.7%
Financing Cash Flow	$-783.0K	↓ 128.04%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$1.8M	↓ 152.88%
Investing Cash Flow	$-103.0K	↑ 10200.0%
Financing Cash Flow	$-650.0K	↓ 16.99%

Rockwell Medical Technicals Summary

Sell

Neutral

Buy

Rockwell Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rockwell Medical Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rockwell Medical Inc	78.89%	7.55%	-47.22%	-8.06%	-88.4%
Haleon Plc Spon Ads	1.5%	-7.33%	-3.49%	69.05%	32.32%
United Therapeutics Corporation	3.57%	-1.69%	-13.51%	34.83%	71.41%
Zoetis Inc.	6.13%	-8.28%	-14.8%	-1.88%	-3.48%
Neurocrine Biosciences Inc.	8.29%	21.94%	11.59%	32.16%	20.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rockwell Medical Inc	NA	NA	-0.79	-0.17	-0.08	-0.02	NA	0.88
Haleon Plc Spon Ads	21.53	21.53	3.14	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.9	11.9	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.97	26.97	2.53	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.3	41.3	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rockwell Medical Inc	Buy	$62.0M	-88.4%	NA	-2.39%
Haleon Plc Spon Ads	Buy	$43.4B	32.32%	21.53	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.41%	11.9	40.36%
Zoetis Inc.	Buy	$69.3B	-3.48%	26.97	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	20.59%	41.3	13.88%

About Rockwell Medical Inc

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. Its hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics, including dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Organization	Rockwell Medical
Employees	244
CEO	Dr. Mark Strobeck Ph.D.
Industry	Health Technology

Key Management of Rockwell Medical Inc

Name	Title
Dr. Mark Strobeck Ph.D.	President, CEO & Director
Mr. Jesse Neri	Senior VP & CFO
Ms. Megan C. Timmins	Executive VP, Chief Legal Officer & Secretary
Mr. Nicholas Fanslau	Controller & Principal Accounting Officer
Mr. Timothy T. Chole	Senior VP & Chief Commercial Officer
Ms. Heather H. Hunter	Senior VP & Chief Corporate Affairs Officer

Important FAQs about investing in RMTI Stock from India :

What is Rockwell Medical share price today?

Rockwell Medical share price today is $1.71 as on August 30, 2025 at 1:29 am IST at the close of the market. Rockwell Medical share today touched a day high of $2.06 and a low of $1.42.

What is the 52 week high and 52 week low for Rockwell Medical share?

Rockwell Medical share touched a 52 week high of $5.15 and a 52 week low of $0.78. Rockwell Medical stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $1.71, lower by 66.8% versus the 52 week high.

How to invest in Rockwell Medical Stock (RMTI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rockwell Medical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rockwell Medical Shares that will get you 0.8772 shares as per Rockwell Medical share price of $1.71 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rockwell Medical Stock (RMTI) from India?

Indian investors can start investing in Rockwell Medical (RMTI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Rockwell Medical stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Rockwell Medical share’s latest price of $1.71 as on August 30, 2025 at 1:29 am IST, you will get 5.8480 shares of Rockwell Medical. Learn more about fractional shares .

What are the returns that Rockwell Medical has given to Indian investors in the last 5 years?

Rockwell Medical stock has given -88.4% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?